Scientific Update – Radiation-releasing “seeds” may slow cholangiocarcinoma growth by inhibiting VEGFR2 singling

External radiation has been used to treat cancer for many years, but recent technological advances have led to a new form of radiation from implanted iodine 125 (125I) “seeds.” This new approach is advantageous since it allows high doses of targeted radiation with minimal damage to surrounding tissues while being more convenient for patients than…

Read More

Scientific Update – Circular RNA (circZNF215) in cholangiocarcinoma: A new possible therapeutic target

About 98% of the human genome is non-coding, meaning it does not contain the genetic code to make proteins. However, these non-coding regions are not “junk DNA.” Instead, they contain important regulatory elements that can affect gene expression, protein levels, and protein activity. One type of non-coding element is circular RNAs, and a recent study…

Read More

Monthly Scientific Update – April 2023

Radiomics Models May Help Identify Candidates for Surgery Most cholangiocarcinoma tumors are unfortunately detected at advanced stages, but surgical resection is sometimes possible for earlier-stage cancers. To better identify patients who may benefit from surgery, researchers are working to develop ways to predict postoperative disease recurrence. A recent study thus identified variables associated with post-surgical…

Read More

Monthly Scientific Update – February 2023

LCK Inhibitor: A Novel Potential Therapy for Cholangiocarcinoma A variety of signaling pathways can become overactive in cancer to promote cell growth. One of these pathways is known as the Hippo signaling pathway, which involves the activation of “yes-associated protein” (YAP). YAP is regulated by another protein called LCK, which can turn on YAP through…

Read More